"Colestipol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic. It may also may reduce triglyceride levels.
Descriptor ID |
D003084
|
MeSH Number(s) |
D02.092.782.200 D05.750.200 D25.720.200 J01.637.051.720.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Colestipol".
Below are MeSH descriptors whose meaning is more specific than "Colestipol".
This graph shows the total number of publications written about "Colestipol" by people in this website by year, and whether "Colestipol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 2 | 2 |
2004 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colestipol" by people in Profiles.
-
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer. Breast. 2023 Feb; 67:94-101.
-
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia. Am J Cardiol. 2004 Sep 15; 94(6):795-7.
-
Choosing the right lipid-regulating agent. A guide to selection. Drugs. 1996 Nov; 52(5):649-61.
-
Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 1996 Apr 01; 93(7):1334-8.
-
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug Saf. 1994 Nov; 11(5):301-9.
-
HMG-CoA reductase inhibitors. A new approach to the management of hypercholesterolemia. Cleve Clin J Med. 1988 Jan-Feb; 55(1):93-100.
-
Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia. J Lab Clin Med. 1985 Oct; 106(4):447-54.